These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17272501)

  • 1. The thymic theme of acetylcholinesterase splice variants in myasthenia gravis.
    Gilboa-Geffen A; Lacoste PP; Soreq L; Cizeron-Clairac G; Le Panse R; Truffault F; Shaked I; Soreq H; Berrih-Aknin S
    Blood; 2007 May; 109(10):4383-91. PubMed ID: 17272501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cytokines on acetylcholine receptor expression: implications for myasthenia gravis.
    Poëa-Guyon S; Christadoss P; Le Panse R; Guyon T; De Baets M; Wakkach A; Bidault J; Tzartos S; Berrih-Aknin S
    J Immunol; 2005 May; 174(10):5941-9. PubMed ID: 15879086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic inactivation of acetylcholinesterase impairs homeostasis in mouse hippocampal granule cells.
    Cohen JE; Zimmerman G; Melamed-Book N; Friedman A; Dori A; Soreq H
    Hippocampus; 2008; 18(2):182-92. PubMed ID: 17960645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense treatment for myasthenia gravis: experience with monarsen.
    Sussman JD; Argov Z; McKee D; Hazum E; Brawer S; Soreq H
    Ann N Y Acad Sci; 2008; 1132():283-90. PubMed ID: 18567879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of TNF-related apoptosis-inducing ligand and receptors and implications in thymus biology and myasthenia gravis.
    Kanatli I; Akkaya B; Uysal H; Kahraman S; Sanlioglu AD
    Neuromuscul Disord; 2017 Feb; 27(2):128-135. PubMed ID: 28012741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukemia inhibitory factor, oncostatin M, IL-6, and stem cell factor mRNA expression in human thymus increases with age and is associated with thymic atrophy.
    Sempowski GD; Hale LP; Sundy JS; Massey JM; Koup RA; Douek DC; Patel DD; Haynes BF
    J Immunol; 2000 Feb; 164(4):2180-7. PubMed ID: 10657672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired hippocampal plasticity and errors in cognitive performance in mice with maladaptive AChE splice site selection.
    Farchi N; Shoham S; Hochner B; Soreq H
    Eur J Neurosci; 2007 Jan; 25(1):87-98. PubMed ID: 17241270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of acetylcholine receptor genes in human thymic epithelial cells: implications for myasthenia gravis.
    Wakkach A; Guyon T; Bruand C; Tzartos S; Cohen-Kaminsky S; Berrih-Aknin S
    J Immunol; 1996 Oct; 157(8):3752-60. PubMed ID: 8871679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central role of interferon-beta in thymic events leading to myasthenia gravis.
    Cufi P; Dragin N; Ruhlmann N; Weiss JM; Fadel E; Serraf A; Berrih-Aknin S; Le Panse R
    J Autoimmun; 2014 Aug; 52():44-52. PubMed ID: 24393484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in acetylcholinesterase in experimental autoimmune myasthenia gravis and in response to treatment with a specific antisense.
    Blotnick E; Hamra-Amitai Y; Wald C; Brenner T; Anglister L
    Eur J Neurosci; 2012 Oct; 36(8):3077-85. PubMed ID: 22805122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological relationship between acetylcholine receptor and thymus: a possible significance in myasthenia gravis.
    Aharonov A; Tarrab-Hazdai R; Abramsky O; Fuchs S
    Proc Natl Acad Sci U S A; 1975 Apr; 72(4):1456-9. PubMed ID: 1055418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential estrogen receptor expression in autoimmune myasthenia gravis.
    Nancy P; Berrih-Aknin S
    Endocrinology; 2005 May; 146(5):2345-53. PubMed ID: 15661863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of readthrough acetylcholinesterase in the pathophysiology of myasthenia gravis.
    Brenner T; Hamra-Amitay Y; Evron T; Boneva N; Seidman S; Soreq H
    FASEB J; 2003 Feb; 17(2):214-22. PubMed ID: 12554700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Il-23/Th17 cell pathway: A promising target to alleviate thymic inflammation maintenance in myasthenia gravis.
    Villegas JA; Bayer AC; Ider K; Bismuth J; Truffault F; Roussin R; Santelmo N; Le Panse R; Berrih-Aknin S; Dragin N
    J Autoimmun; 2019 Mar; 98():59-73. PubMed ID: 30578016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-lasting acetylcholinesterase splice variations in anticholinesterase-treated Alzheimer's disease patients.
    Darreh-Shori T; Hellström-Lindahl E; Flores-Flores C; Guan ZZ; Soreq H; Nordberg A
    J Neurochem; 2004 Mar; 88(5):1102-13. PubMed ID: 15009666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered expression of fragile X mental retardation-1 (FMR1) in the thymus in autoimmune myasthenia gravis.
    Thomas S; Fayet OM; Truffault F; Fadel E; Provost B; Hamza A; Berrih-Aknin S; Bonnefont JP; Le Panse R
    J Neuroinflammation; 2021 Nov; 18(1):270. PubMed ID: 34789272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral site acetylcholinesterase blockade induces RACK1-associated neuronal remodeling.
    Farchi N; Ofek K; Podoly E; Dong H; Xiang YY; Diamant S; Livnah O; Li J; Hochner B; Lu WY; Soreq H
    Neurodegener Dis; 2007; 4(2-3):171-84. PubMed ID: 17596712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylcholinesterase/C terminal binding protein interactions modify Ikaros functions, causing T lymphopenia.
    Perry C; Pick M; Podoly E; Gilboa-Geffen A; Zimmerman G; Sklan EH; Ben-Shaul Y; Diamant S; Soreq H
    Leukemia; 2007 Jul; 21(7):1472-80. PubMed ID: 17476278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased number of Hassall's corpuscles in myasthenia gravis patients with thymic hyperplasia.
    Matsui N; Ohigashi I; Tanaka K; Sakata M; Furukawa T; Nakagawa Y; Kondo K; Kitagawa T; Yamashita S; Nomura Y; Takahama Y; Kaji R
    J Neuroimmunol; 2014 Apr; 269(1-2):56-61. PubMed ID: 24556356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stress-induced alternative splicing of acetylcholinesterase results in enhanced fear memory and long-term potentiation.
    Nijholt I; Farchi N; Kye M; Sklan EH; Shoham S; Verbeure B; Owen D; Hochner B; Spiess J; Soreq H; Blank T
    Mol Psychiatry; 2004 Feb; 9(2):174-83. PubMed ID: 14581933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.